| ||||||||||||||
|
|
|||||||||||||


Departments of *Anesthesiology and
Colon and Rectal Surgery, Tri-Service General Hospital and National Defense Medical Center, National Defense University, Taipei, Taiwan; and
Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina
Address correspondence and reprint requests to Ching-Tang Wu, MD, Department of Anesthesiology, Tri-Service General Hospital and National Defense Medical Center, National Defense University, #325, Section 2, Chenggung Rd., Neihu 114, Taipei, Taiwan, Republic of China. Address e-mail to wuchingtang{at}msn.com
Cytokine release during surgery can produce a long-lasting hyperalgesia. Thus, preoperatively-administered cytokine inhibitors might reduce the production of cytokines, decreasing central nervous system sensitization and improving the quality of postoperative pain relief. We investigated the hypothesis that preincisional IV pentoxifylline (PTX) treatment could attenuate the release of proinflammatory (tumor necrosis factor, interleukin (IL)-1ß, IL-6, and IL-8) and antiinflammatory (IL-1 receptor antagonist) cytokines in patients who underwent elective colorectal cancer surgery. Forty patients were randomly assigned to 1 of 2 groups of 20 each: the PTX group received a PTX 5 mg/kg IV infusion before the induction of anesthesia, whereas the control group received an equal volume of normal saline. Venous blood samples were obtained at frequent intervals. After surgery, all patients received patient-controlled analgesia (PCA) morphine for postoperative pain relief. Patients in the PTX group exhibited longer PCA trigger times, less morphine consumption, and a faster return of bowel function compared with patients in the control group. Moreover, the plasma levels of IL-6, IL-8, and IL-1 receptor antagonist were less in the treatment group, and there was no significant difference in wound infections, tumor recurrence, or metastatic rates between groups during a 2-yr follow-up.
IMPLICATIONS: Preoperative IV pentoxifylline improved postoperative pain, resulting in diminished morphine consumption, faster return of bowel function, and attenuated production of interleukin (IL)-6, IL-8, and IL-1 receptor antagonist in the perioperative period, but it did not increase the risk of complications in this small patient group.
This article has been cited by other articles:
![]() |
C. P. Kuo, S. W. Jao, K. M. Chen, C. S. Wong, C. C. Yeh, M. J. Sheen, and C.T. Wu Comparison of the effects of thoracic epidural analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery Br. J. Anaesth., November 1, 2006; 97(5): 640 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shavit, G. Fish, G. Wolf, E. Mayburd, Y. Meerson, R. Yirmiya, and B. Beilin The Effects of Perioperative Pain Management Techniques on Food Consumption and Body Weight After Laparotomy in Rats Anesth. Analg., October 1, 2005; 101(4): 1112 - 1116. [Abstract] [Full Text] [PDF] |
||||
|